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Scrapie in Swine: a Diagnostic Challenge
Abstract
A naturally occurring prion disease has not been recognized in swine, but the agent of bovine spongiform
encephalopathy does transmit to swine by experimental routes. Swine are thought to have a robust species
barrier when exposed to the naturally occurring prion diseases of other species, but the susceptibility of swine
to the agent of sheep scrapie has not been thoroughly tested. We conducted this experiment to test the
susceptibility of swine to U.S. scrapie isolates by intracranial and oral inoculation. Scrapie inoculum was a
pooled 10% (w/v) homogenate derived from the brains of clinically ill sheep from the 4th passage of a serial
passage study of the U.S scrapie agent (No. 13–7) through susceptible sheep (homozygous ARQ at prion
protein residues 136, 154, and 171, respectively). Pigs were inoculated intracranially (n=19) with a single 0.75
mL dose or orally (n=24) with 15 mL repeated on 4 consecutive days. Necropsies were done on a subset of
animals at approximately six months post inoculation (PI): the time the pigs were expected to reach market
weight. Remaining pigs were maintained and monitored for clinical signs of transmissible spongiform
encephalopathies (TSE) until study termination at 80 months PI or when removed due to intercurrent disease
(primarily lameness). Brain samples were examined by immunohistochemistry (IHC), western blot (WB),
enzyme immunoassay (EIA), and for a subset of pigs in each inoculation group, bioassay in mice expressing
porcine prion protein. At six-months PI, no evidence of scrapie infection was noted by any diagnostic method.
However, at 51 months of incubation or greater, 5 animals were positive by one or more methods: IHC (n=4),
WB (n=3), or EIA (n=4). Furthermore, positive bioassay results were obtained from all inoculated groups
(oral and intracranial; market weight and end of study) suggesting that swine are potential hosts for the agent
of scrapie.
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A naturally occurring prion disease has not been recognized in swine, but the agent of bovine spongiform encephalopa-
thy does transmit to swine by experimental routes. Swine are thought to have a robust species barrier when exposed 
to the naturally occurring prion diseases of other species, but the susceptibility of swine to the agent of sheep scrapie 
has not been thoroughly tested. We conducted this experiment to test the susceptibility of swine to U.S. scrapie isolates 
by intracranial and oral inoculation. Scrapie inoculum was a pooled 10% (w/v) homogenate derived from the brains of 
clinically ill sheep from the 4th passage of a serial passage study of the U.S scrapie agent (No. 13–7) through susceptible 
sheep (homozygous ARQ at prion protein residues 136, 154, and 171, respectively). Pigs were inoculated intracranially 
(n=19) with a single 0.75 mL dose or orally (n=24) with 15 mL repeated on 4 consecutive days. Necropsies were done on 
a subset of animals at approximately six months post inoculation (PI): the time the pigs were expected to reach market 
weight. Remaining pigs were maintained and monitored for clinical signs of transmissible spongiform encephalopathies 
(TSE) until study termination at 80 months PI or when removed due to intercurrent disease (primarily lameness). Brain 
samples were examined by immunohistochemistry (IHC), western blot (WB), enzyme immunoassay (EIA), and for a 
subset of pigs in each inoculation group, bioassay in mice expressing porcine prion protein. At six-months PI, no evi-
dence of scrapie infection was noted by any diagnostic method. However, at 51 months of incubation or greater, 5 ani-
mals were positive by one or more methods: IHC (n=4), WB (n=3), or EIA (n=4). Furthermore, positive bioassay results 
were obtained from all inoculated groups (oral and intracranial; market weight and end of study) suggesting that swine 
are potential hosts for the agent of scrapie.
Key words: prion, scrapie, swine, transmissible spongiform encephalopathy (6)
Prion diseases are a family of fatal neurodegenerative diseases that include scrapie of sheep and goats, bovine 
spongiform encephalopathy (BSE), chronic wasting disease of cervids, and Creutzfeldt-Jakob disease of humans. Trans-
mission of prion diseases amongst animals of the same species can be efficient, but there is often a significant barrier to 
transmission between species1,2). A natural prion disease of pigs has not been described, not even in the UK where pigs 
were likely to have been exposed to BSE contaminated feed prior to 19963).
The ability of a given prion agent to infect some species and not others is referred to as species barrier4–6). The spe-
cies barrier can manifest as lack of disease susceptibility, incomplete attack rates, or prolonged incubation periods. An 
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initial passage is usually not efficient between species, but subsequent passages can lead to stabilization of disease in a 
new species7). The major influence on species barrier is amino acid sequence differences between the donor and recipient 
hosts6,8) and the effect on prion protein structure and folding9).
The susceptibility and incubation periods of prion disease in an individual are highly dependent on the amino acid 
sequence of the prion protein in mice10), sheep11–13), cervids14,15), and humans16). However, compared to sheep, cervids, 
and humans, the porcine prion protein (PrP) is highly homogenous17,18) with only four known single nucleotide polymor-
phisms (G11A, G615C, G684A, T726G) one of which (G615C) that results in a serine to asparagine substitution at codon 
4 that is not part of the mature prion protein19). As compared to cattle, pigs have 5 unique amino acids that appear in the 
prion protein sequence of the globular domain and 4 of these appear in helix 320). While epidemiologic evidence would 
suggest pigs are not susceptible to prion disease, in vitro assays demonstrate that recombinant porcine PrP converts to 
amyloid fibrils faster than human or bovine sequences21).
Several experimental studies have been conducted to test the susceptibility of pigs to prion diseases. The agent 
of BSE transmitted to pigs after multiple-route (concurrent intracranial, intravenous, and intraperitoneal) parenteral 
inoculation with an incubation period of 17–38 months and resulted in severe neuropil vacuolation and abnormal prion 
protein (PrPSc) accumulation in the brain3). Further, infectivity was demonstrated in brain, spinal cord, stomach, small 
intestine, and pancreas by bioassay in C57BLJ6 mice22). However, attempts to transmit BSE to pigs after oral dosing 
with up to 1.2 kg of brain material from infected cattle was unsuccessful23). Studies utilizing transgenic mice expressing 
the porcine prion protein suggest that initial low dose exposure to BSE prions may result in a subclinical infection that 
results in a high attack rate and shortened incubation periods on second passage20).
Piglets exposed orally to brain material from scrapie-infected sheep from the UK lacked any evidence of disease 
and bioassay of tissues from these pigs failed to reveal infectivity in tissues23). However, mice expressing porcine PrP are 
susceptible to atypical (Nor-98) scrapie with a low attack rate that adapts to 100% attack rate with a rapid incubation on 
subsequent passages24), similar to the adaptation that was observed in experiments that were conducted with BSE20,24). 
Interestingly, sheep passaged BSE transmits more efficiently to pigs than BSE from cattle and was associated with PrPSc 
in variety of peripheral tissues25).
We conducted a study to determine if swine were susceptible to an isolate of the US scrapie agent by either the 
intracranial or oral route. Initially, we used transgenic mice expressing porcine prion protein (PoPrP-Tg002) to test 
their susceptibility to the agent of sheep scrapie. No mice in this study developed clinical signs before the end of the 
experiment (700 days), but 5/30 tested positive by enzyme immunoassay (EIA; BSE-Scrapie Antigen Test Kit, IDEXX, 
Westbrook, ME). For the swine study, weaned piglets were inoculated with a 10% (w/v) homogenate made from the 
brains of clinically ill sheep from the 4th passage of a serial passage study of the U.S scrapie agent (No. 13–7) through 
sheep homozygous ARQ at prion protein residues 136, 154, and 171, respectively26). Intracranial inoculations27) (n=19) 
were with a single 0.75 mL dose  of homogenate. Oral inoculations (n=24) were 15 mL doses repeated on 4 consecutive 
days. Necropsies were done on a subset of animals at approximately six months post inoculation (PI): the time the pigs 
were expected to reach market weight. Remaining pigs were maintained and monitored for clinical signs of transmis-
sible spongiform encephalopathies (TSE) until study termination at 80 months PI or when removed due to intercurrent 
disease. Brain samples were examined by immunohistochemistry (IHC)28), western blot (WB)12), enzyme immunoassay 
(EIA)29), and for a subset of pigs in each inoculation group, bioassay in mice expressing porcine PrP.
All pigs examined at market weight tested negative by traditional diagnostic methods. However, 5/10 aged pigs 
that were necropsied at 51 months of age or later tested positive using immunohistochemistry (IHC; n=4)), western blot 
(WB; n=3), and/or EIA (n=4). In all hematoxylin and eosin stained slides examined by light microscopy, there was no 
evidence of spongiform encephalopathy beyond that present in negative control pigs. Examination of slides stained by 
an immunohistochemical method with monoclonal antibody L42 that targets to amino acids 145–163 of the ovine prion 
protein sequence30) demonstrated immunoreactivity that was largely confined within neurons (Fig. 1) and was present 
in hippocampus, cerebellum, thalamus, brainstem, and spinal cord. Findings from HE and IHC were similar to scrapie 
in cattle where spongiform change was not noted and IHC positives had prominent intraneuronal labeling31). In pigs that 
were WB positive, the molecular profile was distinct from the original scrapie inoculum in that the nonglycosylated band 
migrated lower than sheep scrapie and that the profile had a most prominent monoglycosylated rather than diglycosyl-
ated band (Fig. 2).
One pig from each inoculation group was bioassayed in PoPrP-Tg002 mice. Bioassay results were determined by 
EIA. Positive results were obtained from the market weight pigs that were orally (5/29) or intracranially (2/27) inocu-
lated. The sample that was selected from the orally inoculated aged pig (incubation period=50 months) also had a low 
number of positive results (2/24) in mouse bioassay. Interestingly, the aged pigs from the intracranially inoculated pigs 
that were IHC, WB, and/or EIA positive that were selected for bioassay yielded 0/29 and 0/30 positive samples, which 
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was unexpected. This interesting result contrasted those of BSE samples where second passage results in a 100% attack 
rate with a relatively short incubation period20,24). Of great interest are the mice that tested ELISA positive after bioassay 
of brain material from an orally inoculated pig that was examined at market weight. These mice were collected at the 
end of the mouse study that was scheduled to last for 700 days post-inoculation. The positive mice had low EIA optical 
density scores. No vacuolar change was noted on sections available for lesion profiling. A second passage from a positive 
mouse with a positive EIA was attempted in mice expressing porcine prion protein (PoPRP-Tg002) or mice expressing 
sheep prion protein (Tg338). The second passage in PoPRP-Tg002 mice is ongoing, but passage to Tg338 mice resulted 
in 16/20 positive mice. This work demonstrates that pigs are susceptible to the US scrapie agent by oral and intracranial 
inoculation. Aged animals inoculated intracranially were detectable by traditional diagnostic methods, however, orally 
Fig. 1. Immunoreactivity (red) in central nervous system tissues of pigs with scra-
pie is predominantly intraneuronal. High magnification of the brainstem at the level 
of the obex with intraneuronal immunoreactivity after staining with an automated pro-
tocol using monoclonal antibody L42.
Fig. 2. Western blot analysis demonstrating unique PrPSc profile in pigs with 
scrapie. The positive sample from a pig inoculated with the agent of scrapie has a 
prominent monoglycosylated band and lower migration relative to the sheep scrapie 
inoculum. Blot developed with monoclonal antibody L42.
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exposed aged or market weight animals, while positive by bioassay were not detected by any standard diagnostic tech-
nique. Further, no animals demonstrated clinical signs of disease or had spongiform change in their brains.
Pigs were exposed to the agent of BSE in contaminated meat and bone meal in many European countries, but no 
naturally occurring cases have been described and surveys of meat and bone meal fed pigs failed to demonstrate any 
evidence of TSE32). Pigs challenged orally with BSE failed to develop evidence of infection33) despite observation for 
up to seven years22). These previously published studies along with results of the current study suggest that swine are 
capable of harboring a prion disease, although epidemiologic evidence is not in support of this occurring under produc-
tion conditions.
We have demonstrated that swine are susceptible to the agent of sheep scrapie. While no pigs examined at market 
weight were positive by traditional diagnostic methods, there were 5 aged pigs with positive IHC, WB, and/or ELISA 
from brain tissue. These pigs did not have definitive clinical illness or spongiform change during the course of this 
experiment. Positive bioassay results from the brains of market weight pigs suggest that even orally inoculated pigs do 
harbor a low level of infectivity. If scrapie were to occur in pigs, it would represent a significant diagnostic challenge 
because of long incubation periods, failure of pigs to develop clinical signs, and the inability of traditional diagnostic 
methods to detect infected animals early in the course of disease.
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